Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The price of Relay Therapeutics Inc (NASDAQ: RLAY) closed at $3.79 in the last session, up 2.16% from day before closing price of $3.71. In other words, the price has increased by $2.16 from its previous closing price. On the day, 4.5 million shares were traded. RLAY stock price reached its highest trading level at $3.97 during the session, while it also had its lowest trading level at $3.645.
Ratios:
We take a closer look at RLAY’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 19.96 and its Current Ratio is at 19.96. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.06.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wells Fargo on April 17, 2025, initiated with a Equal Weight rating and assigned the stock a target price of $4.
On September 10, 2024, Jefferies Upgraded its rating to Buy which previously was Hold and also upped its target price recommendation from $10.60 to $16.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jul 09 ’25 when Patel Sanjiv sold 61,379 shares for $3.57 per share. The transaction valued at 219,123 led to the insider holds 765,288 shares of the business.
Rahmer Peter sold 10,739 shares of RLAY for $32,217 on Apr 30 ’25. The insider now owns 390,081 shares after completing the transaction at $3.00 per share. On Apr 28 ’25, another insider, Rahmer Peter, who serves as the insider of the company, sold 1,364 shares for $3.17 each. As a result, the insider received 4,324 and left with 400,820 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RLAY now has a Market Capitalization of 649776512 and an Enterprise Value of -13419579. For the stock, the TTM Price-to-Sale (P/S) ratio is 84.61 while its Price-to-Book (P/B) ratio in mrq is 0.90. Its current Enterprise Value per Revenue stands at -1.748 whereas that against EBITDA is 0.036.
Stock Price History:
The Beta on a monthly basis for RLAY is 1.63, which has changed by -0.5816777 over the last 52 weeks, in comparison to a change of 0.17774606 over the same period for the S&P500. Over the past 52 weeks, RLAY has reached a high of $10.72, while it has fallen to a 52-week low of $1.77. The 50-Day Moving Average of the stock is 15.05%, while the 200-Day Moving Average is calculated to be -6.73%.
Shares Statistics:
According to the various share statistics, RLAY traded on average about 1.91M shares per day over the past 3-months and 2383700 shares per day over the past 10 days. A total of 170.48M shares are outstanding, with a floating share count of 129.32M. Insiders hold about 24.57% of the company’s shares, while institutions hold 84.25% stake in the company. Shares short for RLAY as of 1751241600 were 21520044 with a Short Ratio of 11.28, compared to 1748563200 on 22648303. Therefore, it implies a Short% of Shares Outstanding of 21520044 and a Short% of Float of 15.24.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
